Addressing irAEs Limits Interruption or Discontinuation in HCC.

Subjects

Subjects :

PROTEINURIA
DIARRHEA
HEPATITIS
IMMUNOTHERAPY
BEVACIZUMAB
TERMINATION of treatment
IMMUNE checkpoint inhibitors
PROGRESSION-free survival
HEPATOCELLULAR carcinoma
OVERALL survival

Details

Language :

English

ISSN :

15398226

Volume :

13

Issue :

5

Database :

Complementary Index

Journal :

Targeted Therapies in Oncology

Publication Type :

Periodical

Accession number :

176733836